Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular matrix-receptor interaction refers to the ensemble of biochemical and biomechanical connections that occur between extracellular matrix components (such as collagens, fibronectin, laminins, and glycoproteins) and cell surface receptors (including integrins, syndecans, discoidin domain receptors, and others)[1][3][5][6]. These interactions serve as physical anchors and transmit essential regulatory signals influencing cellular adhesion, migration, proliferation, differentiation, immune surveillance, and response to injury. They are central to tissue development, maintenance, and pathology, including cancer progression, fibrosis, and inflammatory diseases[2][4]. Therapeutic modulation of ECM–receptor interactions generally targets specific receptors (such as integrins) or enzymes involved in ECM remodeling, not the interaction process as a unified drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix-receptor interaction.